Harish Shantharam serves as Executive at CymaBay Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Harish Shantharam has executed 3 insider transactions totaling $58.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 18, 2025 involved purchasing 75,000 shares valued at $58.5K.
Harish Shantharam currently holds 75,000 shares of CymaBay Therapeutics, Inc. (CBAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harish Shantharam has been a net buyer of CBAY stock. They have purchased $58.5K and sold $0 worth of shares.
Harish Shantharam's most recent insider trade was on Aug 18, 2025, when they purchased 75,000 shares at $0.78 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 24, 2024 | CBAY | $0 | Award | 20,125 | $N/A | Discretionary |